iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Update

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) saw a large growth in short interest in February. As of February 13th, there was short interest totaling 33,149 shares, a growth of 277.5% from the January 29th total of 8,781 shares. Approximately 0.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 48,195 shares, the days-to-cover ratio is presently 0.7 days. Based on an average daily trading volume, of 48,195 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.7% of the shares of the stock are sold short.

iShares Genomics Immunology and Healthcare ETF Stock Performance

Shares of NYSEARCA IDNA traded up $0.24 during trading hours on Friday, hitting $31.13. 28,566 shares of the stock were exchanged, compared to its average volume of 42,663. The company’s fifty day simple moving average is $28.51 and its two-hundred day simple moving average is $25.89. The company has a market cap of $155.65 million, a PE ratio of 14.76 and a beta of 1.07. iShares Genomics Immunology and Healthcare ETF has a 1-year low of $17.26 and a 1-year high of $31.39.

Hedge Funds Weigh In On iShares Genomics Immunology and Healthcare ETF

Several hedge funds and other institutional investors have recently modified their holdings of the business. Triumph Capital Management acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the 3rd quarter valued at $35,000. Ameriprise Financial Inc. boosted its stake in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after purchasing an additional 5,540 shares in the last quarter. Portland Global Advisors LLC boosted its stake in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% during the third quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock valued at $2,432,000 after purchasing an additional 684 shares in the last quarter. Finally, Flow Traders U.S. LLC bought a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter worth about $931,000.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.